Pharma Co. Misled Investors On Depression Drug, Suit Says
By Sydney Price · February 10, 2025, 9:20 PM EST
Brain disease drugmaker Neumora Therapeutics Inc. has been hit with a proposed shareholder class action alleging that the company and its initial public offering underwriters failed to disclose prior to the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login